Detalhe da pesquisa
1.
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
Pediatr Dermatol
; 40(3): 452-459, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36949579
2.
Oxymetazoline and Energy-Based Therapy in Patients with Rosacea: Evaluation of the Safety and Tolerability in an Open-Label, Interventional Study.
Lasers Surg Med
; 53(1): 55-65, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32378241
3.
Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex.
J Drugs Dermatol
; 20(6): 608-615, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34076400
4.
Fixed-Combination Halobetasol Propionate/Tazarotene Lotion for Psoriasis in Patients With 3%-5% Affected Body Surface Area.
J Drugs Dermatol
; 20(8): 829-836, 2021 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34397206
5.
New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis.
J Drugs Dermatol
; 19(6): 602-610, 2020 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32574011
6.
Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis.
J Drugs Dermatol
; 19(3): 272-279, 2020 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32549090
7.
Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials
J Drugs Dermatol
; 19(1): 70-77, 2020 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31985914
8.
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris
J Drugs Dermatol
; 18(6): 542, 2019 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31251546
9.
WITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials.
J Am Acad Dermatol
; 2018 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-29409915
10.
Clinical Experience With Once-Daily Dapsone Gel, 7.5% Monotherapy in Patients With Acne Vulgaris.
J Drugs Dermatol
; 17(6): 602-608, 2018 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29879247
11.
Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies.
J Drugs Dermatol
; 17(8): 855-861, 2018 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30124724
12.
Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.
J Drugs Dermatol
; 17(6): 621-626, 2018 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29879249
13.
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
J Drugs Dermatol
; 17(3): 290-298, 2018 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29537447
14.
Short-pulsed laser for the treatment of tattoos, pigmented lesions, scars and rejuvenation.
Semin Cutan Med Surg
; 36(4): 148-154, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29224031
15.
The histology of skin treated with a picosecond alexandrite laser and a fractional lens array.
Lasers Surg Med
; 48(7): 646-52, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27252086
16.
Comparison of the Cutaneous Thermal Signatures Over Twenty-Four Hours With a Picosecond Alexandrite Laser Using a Flat or Fractional Optic.
J Drugs Dermatol
; 15(11): 1347-1352, 2016 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28095546
17.
A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines.
Dermatol Surg
; 41(11): 1310-9, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26509943
18.
A Controlled Comparison Study of Topical Fluourouracil 5% Cream Pre-Treatment of Aminolevulinic Acid/Photodynamic Therapy for Actinic Keratosis.
J Drugs Dermatol
; 14(11): 1241-4, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26580872
19.
Impact of female acne on patterns of health care resource utilization.
J Drugs Dermatol
; 14(2): 140-8, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25689809
20.
Optimizing the use of topical brimonidine in rosacea management: panel recommendations.
J Drugs Dermatol
; 14(1): 33-40, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25607906